Merger and rebrand of three of the UK’s leading healthcare providers to form Vita Health Group
ArchiMed, European private equity healthcare specialist, announces rebranding of its portfolio company, RehabWorks. The text below is an extract of Vita Health Group Announcement.
Merger and rebrand of three of the UK’s leading healthcare providers to form a connected health service
Vita Health Group formed over the past 3 years, and comprises of three leading UK healthcare providers, each with their own proven track-record and reputation within the physical and mental healthcare industry, namely:
- RehabWorks (mental and physical health provider; established 1987)
- Workplace Wellness (mental health provider; established 1989)
- Crystal Palace Physio Group (physical health provider; established 1998)
The Group has been formed to combine the strengths and expertise of each of the individual entities, with an overall objective to becoming the UK’s leading provider of physical and mental health services. We are delighted to be rebranding with a fresh new name and look. Vita Health Group will replace our previous brand name/s from the 1st of July 2019.
To read the full text: Important Announcement
About ArchiMed – www.archimed-group.eu – ArchiMed is an independent investment firm specialized in the Healthcare industries. It is a strategic and financial partner to European and North American companies operating in the Biopharma, Medtech, Diagnostics, Life Sciences, Healthcare IT, Consumer Health, Public Safety and Care Services sectors.
ArchiMed’s international team combines investment, medical, technological and operational experience. It works alongside management teams to accelerate their business growth, through internationalization, product and service range expansion as well as capacity extension, both organically and through acquisitions. Over the last 20 years, ArchiMed’s leadership team directly managed and invested in over 40 small, medium and large size healthcare companies throughout the world, with a combined value above five billion euros.
ArchiMed’s investment capacity currently exceeds one billion euros and potentially twice this amount when including its strategic investment partners.